Patient preference and acceptability of self-sampling for cervical screening in colposcopy clinic attenders: A cross-sectional semi-structured survey
- PMID: 38781145
- PMCID: PMC11115198
- DOI: 10.1371/journal.pgph.0003186
Patient preference and acceptability of self-sampling for cervical screening in colposcopy clinic attenders: A cross-sectional semi-structured survey
Abstract
Low vaginal self-sampling has been pioneered as an important development to improve uptake of cervical screening globally. Limited research is available in specific patient groups in the UK exploring views around self-sampling to detect high-risk human papillomavirus (hrHPV) DNA. Therefore, we explored patient views to support development of a novel point-of-care self-sampling cervical cancer screening device, by undertaking a cross-sectional semi-structured questionnaire survey to explore preferences, acceptability, barriers and facilitators around self-sampling. Patients attending a colposcopy clinic, 25-64 years old, were invited to participate after having carried out a low vaginal self-sample using a regular flocked swab. Participants self-completed an anonymous 12-point questionnaire. Quantitative data were analysed in MS Excel and Graphpad Prism, and qualitative data with Nvivo. We recruited 274 patients with a questionnaire response rate of 76%. Acceptability of self-sampling was high (95%, n = 187/197; Cronbachs-α = 0.778). Participants were asked their choice of future screening method: a) low vaginal self-sampling, b) healthcare professional collected vaginal swab, c) cervical brush sample with healthcare professional speculum examination, or d) no preference. Preferences were: a) 37% (n = 74/198), b) 19% (n = 37/198); c) 9% (n = 17/198), and d) 35% (n = 70/198), showing no single option as a strong preference. Key motivators were: Test simplicity (90%, n = 170/190), speed (81%, n = 153/190) and less pain (65%, n = 123/190). Barriers included lack of confidence taking the sample (53%, n = 10/19), resulting in preference for a healthcare professional sample (47%, n = 9/19). Whilst self-sampling showed high acceptability, lack of strong preference for screening method may reflect that respondents attending colposcopy are already engaged with screening and have differing perception of cervical cancer risk. This group appear less likely to 'switch' to self-sampling, and it may be better targeted within primary and community care, focusing on under-screened populations. Any shift in this paradigm in the UK requires comprehensive education and support for patients and providers.
Copyright: © 2024 Webb et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: SK and HMS are advisors to and shareholders in QuantuMDx, a molecular nucleic acid test-based diagnostic company. SK, YA and HMS are advisors to Global Access Diagnostics, a developer of rapid diagnostic tests, and SK is a member of the Scientific Advisory Committee for the Foundation for Innovative New Diagnostics (FIND), a not-for-profit organisation that produces global guidance on affordable diagnostics. These competing interests will not alter adherence to PLOS Global Public Health policies on sharing data and materials.
Figures
Similar articles
-
The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.Cancer Prev Res (Phila). 2021 Jan;14(1):105-112. doi: 10.1158/1940-6207.CAPR-20-0280. Epub 2020 Sep 11. Cancer Prev Res (Phila). 2021. PMID: 32917643
-
Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.Int J Environ Res Public Health. 2020 Aug 27;17(17):6245. doi: 10.3390/ijerph17176245. Int J Environ Res Public Health. 2020. PMID: 32867315 Free PMC article.
-
Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.PLoS One. 2018 Mar 14;13(3):e0190172. doi: 10.1371/journal.pone.0190172. eCollection 2018. PLoS One. 2018. PMID: 29538411 Free PMC article. Clinical Trial.
-
HPV self-sampling acceptability and preferences among women living with HIV in Botswana.Int J Gynaecol Obstet. 2019 Dec;147(3):332-338. doi: 10.1002/ijgo.12963. Epub 2019 Oct 2. Int J Gynaecol Obstet. 2019. PMID: 31489627 Free PMC article.
-
Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.Front Public Health. 2022 Dec 8;10:1003461. doi: 10.3389/fpubh.2022.1003461. eCollection 2022. Front Public Health. 2022. PMID: 36568753 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al.. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians 2021. May;71(3[14]):209–249. doi: 10.3322/caac.21660 - DOI - PubMed
-
- World Health Organisation. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020. https://www.who.int/publications/i/item/9789240014107.
-
- NHS Digital. Cervical Screening Programme, England—2022–2023. https://digital.nhs.uk/data-and-information/publications/statistical/cer.... Accessed December, 2023.
-
- Jo’s Cervical Cancer Trust. The growing issue of access to cervical screening across the UK: The problems and how they can be overcome. 2018; Available at: https://www.jostrust.org.uk/sites/default/files/final_accessibility_poli.... Accessed 09/02/2023.
LinkOut - more resources
Full Text Sources